pneumonia Mar 9, 2020 Ortho Clinical Diagnostics Procalcitonin Assay Receives FDA Clearance Dec 20, 2019 FDA Clears Curetis Lower Respiratory Tract Infections Panel Nov 1, 2019 Swiss Study Underscores Concerns About Procalcitonin Testing for Pneumonia Premium Jul 11, 2019 Cancer, Vascular Events, Infections Account for Vast Majority of Misdiagnosis-Related Harm, Study Says Apr 11, 2019 Curetis 2018 Revenues Grow 17 Percent Feb 6, 2019 AstraZeneca Spinoff Entasis Inks Deal to Use BioFire Tests Feb 4, 2019 Curetis Partner Submits MDx System, Pneumonia Test for Chinese Regulatory Approval Jan 30, 2019 Curetis Receives Malaysia, Thailand Regulatory Approvals Dec 13, 2018 Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring Nov 30, 2018 Accelerate Diagnostics Seeks to Improve on 'Gold Standard' Culture Test for Clinical Trials Premium Nov 13, 2018 BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark Nov 7, 2018 Avisa Pharma Developing Breath Testing for Pneumonia, C. Diff Premium Oct 11, 2018 Curetis Extends Distribution Agreement With Beijing Clear Biotech in China May 17, 2018 Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test Apr 19, 2018 BioMérieux Q1 Revenues Up 3 Percent Apr 4, 2018 Curetis Unyvero System, Lower Respiratory Tract Infection Cartridge Get FDA Clearance Feb 15, 2018 Accelerate Diagnostics Posts Sharp Q4 Revenue Increase Feb 6, 2018 Curetis Gets Singapore Approval for Pneumonia Test Jan 10, 2018 Accelerate Diagnostics Receives CE-IVD Marking for Pneumonia Infections Test; Q4 Revenues Rise Jul 31, 2017 IDbyDNA, ARUP Laboratories Partner to Develop, Commercialize NGS Infectious Disease Tests Load More Breaking News In Brief This Week: NIH, Thermo Fisher Scientific, Biocept, Castle Biosciences, Biodesix Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test FDA Grants EUAs to Lucira Health Molecular COVID/Flu Test, Azure Biotech, CorDx COVID Antigen Tests Biocare Medical Acquires Empire Genomics Meridian Bioscience Fiscal Q4 Revenues Fall 14 Percent, Full-Year Revenues Grow 5 Percent Japanese Consortium Launches Study to Evaluate Utility of Blood-Based Alzheimer's Markers
